- CMC Biologics today announced the execution of an ...
- Two publicly traded companies will offer shareholder distinct opportunities given unique ...
- Roche Professional Diagnostics and Diagnostica Stago announced today that the ...
- March 2011 Data Confirm Strong Treatment Effect of ...
- In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...
- - This release is not intended for US ...
- This Release is Not Intended for US Media ...
- - This release is not intended for US and Canadian media ...
-Analysis evaluated efficacy and safety among three patient sub-groups A new ...
-Initial Results are Encouraging, Spurring Hope for a Treatment Option with a Lower Rate of ...
- Jubilant Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and ...
- Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo ...
- - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...
- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...
Professor Ian Frazer, creator of the HPV vaccine against cervical cancer will visit Indonesia from 25 to 28 April ...